about
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptorTranslocator protein ligands as promising therapeutic tools for anxiety disordersAnxiolytic-like effects of N,N-dialkyl-2-phenylindol-3-ylglyoxylamides by modulation of translocator protein promoting neurosteroid biosynthesis3-Aryl-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-ones: tricyclic heteroaromatic derivatives as a new class of benzodiazepine receptor ligands1,2,4-Triazolo[4,3-a]quinoxalin-1-one: a versatile tool for the synthesis of potent and selective adenosine receptor antagonistsThe oxysterol-CXCR2 axis plays a key role in the recruitment of tumor-promoting neutrophilsCloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptorPeripheral benzodiazepine receptor ligands: mitochondrial transmembrane potential depolarization and apoptosis induction in rat C6 glioma cellsTSPO over-expression increases motility, transmigration and proliferation properties of C6 rat glioma cellsSynthesis and biological data of 4-amino-1-(2-chloro-2-phenylethyl)-1H-pyrazolo[3,4-b]pyridine-5-carboxylic acid ethyl esters, a new series of A1-adenosine receptor (A1AR) ligands.1,2,4-Triazolo[1,5-a]quinoxaline derivatives: synthesis and biological evaluation as adenosine receptor antagonists.2-aryl-8-chloro-1,2,4-triazolo[1,5-a]quinoxalin-4-amines as highly potent A1 and A3 adenosine receptor antagonists.1,2,4-Triazolo[1,5-a]quinoxaline as a versatile tool for the design of selective human A3 adenosine receptor antagonists: synthesis, biological evaluation, and molecular modeling studies of 2-(hetero)aryl- and 2-carboxy-substituted derivatives.A ferritin-cyclohexyladenosine probe for electron microscope localization of A1 adenosine receptor.Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repairFrontal affinity chromatography-mass spectrometry useful for characterization of new ligands for GPR17 receptor.A rapid and efficient immunoenzymatic assay to detect receptor protein interactions: G protein-coupled receptorsGenetic analysis of dTSPO, an outer mitochondrial membrane protein, reveals its functions in apoptosis, longevity, and Ab42-induced neurodegeneration.Multiscale morphology of organic semiconductor thin films controls the adhesion and viability of human neural cells.Pyrazolo[1,5-a]pyrimidine acetamides: 4-Phenyl alkyl ether derivatives as potent ligands for the 18 kDa translocator protein (TSPO).A3 adenosine receptors in human astrocytoma cells: agonist-mediated desensitization, internalization, and down-regulation3-(Fur-2-yl)-10-(2-phenylethyl)-[1,2,4]triazino[4,3-a]benzimidazol-4(10H)-one, a novel adenosine receptor antagonist with A(2A)-mediated neuroprotective effects.Synthesis and evaluation of translocator 18 kDa protein (TSPO) positron emission tomography (PET) radioligands with low binding sensitivity to human single nucleotide polymorphism rs6971.Modulation of A1 and A2B adenosine receptor activity: a new strategy to sensitise glioblastoma stem cells to chemotherapy.Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiationAn antibody-free strategy for screening putative HDM2 inhibitors using crude bacterial lysates expressing GST-HDM2 recombinant protein.Human glioblastoma multiforme: p53 reactivation by a novel MDM2 inhibitor.Evaluation of novel N1-methyl-2-phenylindol-3-ylglyoxylamides as a new chemotype of 18 kDa translocator protein-selective ligand suitable for the development of positron emission tomography radioligands.Combined inhibition of AKT/mTOR and MDM2 enhances Glioblastoma Multiforme cell apoptosis and differentiation of cancer stem cells.1,2,4-triazolo[1,5-a]quinoxaline derivatives and their simplified analogues as adenosine A₃ receptor antagonists. Synthesis, structure-affinity relationships and molecular modeling studies.Theranostic properties of a survivin-directed molecular beacon in human melanoma cells.Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitorsNew Indole Tubulin Assembly Inhibitors Cause Stable Arrest of Mitotic Progression, Enhanced Stimulation of Natural Killer Cell Cytotoxic Activity, and Repression of Hedgehog-Dependent Cancer.An Effective Virtual Screening Protocol To Identify Promising p53-MDM2 Inhibitors.Lactate dehydrogenase-A inhibition induces human glioblastoma multiforme stem cell differentiation and deathThe role of newer antiglutamatergic agents as mood-stabilizers in bipolar disorder.Toward highly potent cancer agents by modulating the C-2 group of the arylthioindole class of tubulin polymerization inhibitorsRegulation of Erythropoietin Receptor Activity in Endothelial Cells by Different Erythropoietin (EPO) Derivatives: An in Vitro Study.Long lasting MDM2/Translocator protein modulator: a new strategy for irreversible apoptosis of human glioblastoma cells.
P50
Q24672638-0AEB9805-086A-49B1-B90D-82E199C0BEE3Q28249604-33AC088D-6C45-4A69-A13E-303B9724034DQ28291960-FB2E420D-06BE-4053-8DFC-FE08B668C983Q28368241-DE127704-BA10-48CC-AC55-F11491B4F63BQ28374524-896EEFD7-1B89-4BFD-9983-F4D2E039D5A7Q28387803-A1723C28-A302-42FA-8127-52F9A8727334Q28569528-BDF073E2-6DB4-4111-8B70-FE81300530B3Q28576884-005BA4A7-1877-46CE-B1D9-4C7AFE977112Q28579772-A123CD46-BB6C-4E92-A864-B9A6FEC44CBFQ30660369-EDF077E9-9321-4729-813B-FA6DED543151Q33197898-838B179F-BAEE-4871-8EB4-01F3A709208DQ33210937-D82F1D9A-439B-4163-90C7-D8BD1EEF4FB6Q33228823-C2075FD6-7E1E-4B14-B684-BE5F2C998915Q33300186-1AA8EA82-8E29-4A4E-9C76-4A82AA0737ABQ33323622-79B57D4F-09DC-4D3D-B9C3-D69BD32BC8BBQ33381627-EC7972EF-B492-46F2-8C6D-F0E5F33C9B26Q33556111-D4526C94-7DFF-44F8-9492-5A42BDB8C97EQ33580640-E7D65442-D275-4BA6-8580-8914AA2BD166Q33827322-DD2041DD-E68A-4E2C-8F3A-CCACC5E13E26Q33908375-E060948F-7C76-44DE-B5C8-191052E9934CQ34132443-DC0FB975-EA55-4FD6-8006-C645A5D2A2BEQ34159374-927D10E2-F52B-42C4-9460-4C18B0457ADCQ34365007-C514668F-635C-4DC6-94D3-B04A0EEC0D3AQ34408079-16077F42-926D-4D68-8042-48F528921D86Q34662274-D03A805E-2798-4CA5-9296-43DDD9391966Q34695912-C487AF9C-7A44-4E9B-B54B-8EE3424ECD70Q34754934-E5767E00-6EBF-48C9-B6EA-4655C669505FQ34973753-4EDA40AA-AA6A-4DBC-BE6C-F0275706F127Q35103479-423D44E5-8B75-4AE0-9A3D-66E84984B048Q35505109-859C5A37-0AC6-4AAB-9162-EB22DED9D883Q35511885-69DF3644-6BAF-41EE-ADB2-336B63B1F213Q35515042-55D2307C-1014-40AD-B78C-E05DCB362964Q35871254-C1144B16-BBC0-4C76-853B-739F5CAB9B09Q36004162-0421949D-2B05-4E7A-9847-7CBAA2FE0459Q36043034-B21C8118-B7DF-42A3-8259-E7A1D3984A05Q36192530-BBD115C9-508E-4AF4-B087-B75E436E5FC5Q36198797-A63AEFCE-0083-4918-BA29-7863688BAA43Q36584618-CBC84766-E9E1-4818-8289-0FC063440CE7Q36655932-6413F119-916E-4E89-9A6C-AC6C36A21789Q36946655-2D3C5D48-9356-412C-B877-2FA66DC17861
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Claudia Martini
@ast
Claudia Martini
@en
Claudia Martini
@es
Claudia Martini
@nl
Claudia Martini
@sl
type
label
Claudia Martini
@ast
Claudia Martini
@en
Claudia Martini
@es
Claudia Martini
@nl
Claudia Martini
@sl
altLabel
C Martini
@en
prefLabel
Claudia Martini
@ast
Claudia Martini
@en
Claudia Martini
@es
Claudia Martini
@nl
Claudia Martini
@sl
P106
P1153
56400324000
7101640336
P21
P31
P4012
P496
0000-0001-9379-3027